Cargando…
吉非替尼对比培美曲塞二线治疗晚期非鳞型非小细胞肺癌的随机对照临床研究
BACKGROUND AND OBJECTIVE: Geftinib and Pemetrexed are drugs used as second-line therapy for advanced non-small cell lung cancer (NSCLC), although studies comparing the two drugs are limited. The aim of this study is to explore the effects, safety, and quality of life (QoL) of Geftinib and Pemetrexed...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000663/ https://www.ncbi.nlm.nih.gov/pubmed/23945243 http://dx.doi.org/10.3779/j.issn.1009-3419.2013.08.03 |